Reliq Health Technologies Stock Annual Yield
RHT Stock | CAD 0.22 0.00 0.00% |
Reliq Health Technologies fundamentals help investors to digest information that contributes to Reliq Health's financial success or failures. It also enables traders to predict the movement of Reliq Stock. The fundamental analysis module provides a way to measure Reliq Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reliq Health stock.
Reliq | Annual Yield |
Reliq Health Technologies Company Annual Yield Analysis
Reliq Health's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Reliq Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Reliq Health is extremely important. It helps to project a fair market value of Reliq Stock properly, considering its historical fundamentals such as Annual Yield. Since Reliq Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Reliq Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Reliq Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
Reliq Free Cash Flow Yield
Free Cash Flow Yield |
|
In accordance with the recently published financial statements, Reliq Health Technologies has an Annual Yield of 0.0%. This indicator is about the same for the Health Care Technology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Reliq Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Reliq Health from analyzing Reliq Health's financial statements. These drivers represent accounts that assess Reliq Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Reliq Health's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 30.8M | 36.5M | 76.6M | 87.0M | 2.4M | 2.3M | |
Enterprise Value | 30.4M | 37.0M | 76.8M | 87.1M | 2.4M | 2.3M |
Reliq Fundamentals
Return On Equity | -0.0449 | ||||
Return On Asset | -0.053 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | 0.13 % | ||||
Current Valuation | 43.39 M | ||||
Shares Outstanding | 196.76 M | ||||
Shares Owned By Insiders | 1.76 % | ||||
Shares Owned By Institutions | 2.81 % | ||||
Number Of Shares Shorted | 504.11 K | ||||
Price To Book | 5.12 X | ||||
Price To Sales | 3.19 X | ||||
Revenue | 14.62 M | ||||
Gross Profit | 5.3 M | ||||
EBITDA | (1.21 M) | ||||
Net Income | (8.17 M) | ||||
Cash And Equivalents | 1.92 M | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 305 K | ||||
Current Ratio | 5.40 X | ||||
Book Value Per Share | 0.07 X | ||||
Cash Flow From Operations | (8.03 M) | ||||
Short Ratio | 13.30 X | ||||
Earnings Per Share | (0.02) X | ||||
Target Price | 1.75 | ||||
Beta | 1.54 | ||||
Market Capitalization | 46.65 M | ||||
Total Asset | 10.27 M | ||||
Retained Earnings | (69.87 M) | ||||
Working Capital | 3.26 M | ||||
Net Asset | 10.27 M |
About Reliq Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reliq Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reliq Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reliq Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Reliq Stock Analysis
When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.